This page shows the latest Proteomics news and features for those working in and with pharma, biotech and healthcare.
The drug discovery company will use its platform, which combines high-throughput chemoproteomics-based screening in the native setting with structural proteomics.
The study, which saw the company collaborate with the National Institute of Neurological Disorders and Stroke, involved researchers measuring proteomic changes in the cerebrospinal fluid of MS patients treated with tolebrutinib,
In the study, CMRI’s ProCan team used mass spectrometry to measure thousands of different proteins in very large numbers of cancers and, using this methodology, generated a proteomic database for ... Commenting on the study’s results, Roger Reddel, a
As part of the study, scientists carried out ‘proteomic’ analyses and observed changes in 52 key proteins and their interaction with each other in response to drug treatments.
launched a biomarker and proteomics alliance with the Medicines Discovery Catapult.
Will also advance proteomics research. The UK’s Medicines Discovery Catapult has teamed up with LifeArc in a bid to develop novel biomarkers and optimise the medical charity's drug development. ... This new post-doc will centre around proteomics, the
More from news
Approximately 1 fully matching, plus 21 partially matching documents found.
Advances in genomics, proteomics and other areas of scientific research have led to a better understanding of the underlying mechanisms of many rare diseases, providing new targets for drug development.
The science of ‘omics’ – genomics, proteomics, metabolomics – has already taught us that the Big C is far from a singular entity, but is more like thousands of individual diseases caused by
analysis of ‘big data’, genomic and proteomic diagnosis and personalised medicine.
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
He also served as president of ProteoPlex, a seed stage spinout focusing on proteomics, which was acquired by Merck KGaA in 2003, and founded Genomes Systems, acquired by Incyte Genomics in
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
We need mathematicians and engineers, too. Frankly, biomarker research tends attract biologists interested in areas such as genomics and proteomics rather than engineers.
Joshua Yang, Co-founder &CEO of Glyphic Biotechnologies and Co-founder of NephroSant, dives into next-generation protein sequencing for biomedical research and clinical medicine, his journey from academia to entrepreneurship, and much more.
With a background in Advanced Genomic and Proteomic Sciences, he decided to channel his knowledge into supporting clinical research clients solve their complex problems.
JPT Peptide Technologies GmbH is a leading provider of innovative peptide-based services, and catalog products &kits, as well as a research and development partner for projects in Immunotherapy, Immunology, Proteomics
Creative Proteomics provides a comprehensive range of proteomics services using both gel-based and gel-free proteome analysis platforms. ... We offer quality proteomics services for target identification, lead optimization and preclinical and clinical
More from PMHub
Approximately 1 fully matching, plus 4 partially matching documents found.
No results were found
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....